[1] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).中华传染病杂志,2011,29: 65-80.
[2] 中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案. 中华肝脏病杂志,2000,8:324-329.
[3] Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003, 38: 518-526.
[4] Liao B, Wang Z, Lin S, et al. Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT. PLoS One, 2013, 8: e78672.
[5] Chao DT, Lim JK, Ayoub WS, et al. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis. Aliment Pharmacol Ther, 2014, 39: 349-358.
[6] 郜玉峰,邹桂舟,叶珺,等. 431例慢性乙型肝炎病毒感染者临床指标与肝脏病理分析.中华疾病控制杂志,2014,18:964-967.
[7] Hui AY, Chan HL, Wong VW, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol, 2005, 100: 616-623.
[8] Myers RP, Tainturier MH, Ratziu V, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol, 2003, 39:222-230.
[9] Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosisin patients with hepatitis C virus infection: a prospective study. Lancet, 2001, 357:1069-1075.
[10] Forns X, Ampurdanes S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology, 2002, 36:986-992.
[11] Patel K, Gordon SC, Jacobson I, et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol,2004, 41:935-942.
[12] Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology, 2004, 127:1704-1713.
[13] Adams LA, Bulsara M, Rossi E, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.Clin Chem, 2005, 51:1867-1873.
[14] Cales P, Oberti F, Michalak S, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology, 2005, 42:1373-1381.
[15] Lok AS, Ghany MG, Goodman ZD, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests:results of the HALT-C cohort. Hepatology, 2005, 42:282-292.
[16] Fontana RJ, Kleiner DE, Bilonick R, et al. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology,2006, 44:925-935.
[17] Koda M, Matunaga Y, Kawakami M, et al. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology, 2007, 45:297-306.
[18] Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology,2007, 46:32-36.
[19] Zeng MD, Lu LG, Mao YM, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology,2005, 42:1437-1445.
[20] 肝脏硬度评估小组.瞬时弹性成像技术诊断肝纤维化专家意见.中华肝脏病杂志,2013,21:420-424. |
